NATHAN FOWLER to Administration, Oral
This is a "connection" page, showing publications NATHAN FOWLER has written about Administration, Oral.
Connection Strength
0.133
-
Bruton tyrosine kinase inhibitor ibrutinib (PCI-32765) has significant activity in patients with relapsed/refractory B-cell malignancies. J Clin Oncol. 2013 Jan 01; 31(1):88-94.
Score: 0.078
-
Ibrutinib and Venetoclax for First-Line Treatment of CLL. N Engl J Med. 2019 05 30; 380(22):2095-2103.
Score: 0.031
-
Oral lenalidomide with rituximab in relapsed or refractory diffuse large cell, follicular and transformed lymphoma: a phase II clinical trial. Leukemia. 2013 Sep; 27(9):1902-9.
Score: 0.020
-
Quinidine for prophylaxis of arrhythmias in acute myocardial infarction. N Engl J Med. 1971 Oct 28; 285(18):979-86.
Score: 0.005